Feature Channels: Vaccines

Filters close
Released: 21-May-2024 3:05 PM EDT
New clinic-based study shows a program created by UTHealth Houston researchers can improve HPV vaccination rates among youth
University of Texas Health Science Center at Houston

A program for clinic systems created by researchers at UTHealth Houston called the Adolescent Vaccination Program (AVP) has proven to be effective at increasing human papillomavirus (HPV) vaccination rates among adolescents according to a new study published in Vaccines.

Newswise: Tennant_Sharon.jpg
Released: 21-May-2024 12:05 PM EDT
University of Maryland School of Medicine Launches Vaccine Development Program to Prevent Sepsis in Newborns
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants.

Newswise: Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Released: 20-May-2024 10:05 AM EDT
Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
Binghamton University, State University of New York

What’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.

Newswise: Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Released: 17-May-2024 1:05 PM EDT
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Washington University in St. Louis

A study by researchers at Washington University School of Medicine in St. Louis has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19, as well as related coronaviruses.

Newswise: Vivek%20Kumar%20with%20hydrogels-resize.jpg?itok=Ls_qh5Tc
Released: 17-May-2024 1:05 PM EDT
NJIT Engineers Muffle Invading Pathogens with a 'Molecular Mask'
New Jersey Institute of Technology (NJIT)

Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their effectiveness and even render them obsolete.

   
Newswise: Social distancing plus vaccines prevented 800,000 COVID deaths - but at great cost
Released: 14-May-2024 2:05 PM EDT
Social distancing plus vaccines prevented 800,000 COVID deaths - but at great cost
University of Colorado Boulder

Changing people’s behavior until a vaccine could be developed prevented roughly 800,000 COVID-19 deaths in the U.S., according to new CU Boulder and UCLA research. But the authors stress that interventions like lockdowns and school closures came at great economic and social cost.

Newswise: Mobile teams bring COVID-19 vaccines to rural villages in Sierra Leone
Released: 7-May-2024 4:05 PM EDT
Mobile teams bring COVID-19 vaccines to rural villages in Sierra Leone
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

A new international research project showed that intervention with mobile vaccination teams in Sierra Leone is an effective way of reaching rural populations to increase COVID-19 vaccination rates.

Released: 29-Apr-2024 1:05 PM EDT
Study Finds School Entry Requirements Linked to Increased HPV Vaccination Rates
Wake Forest University School of Medicine

A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.

Released: 26-Apr-2024 12:05 PM EDT
Texas Biomed Researching Vaccines and Treatments for Highly Pathogenic Avian Influenza
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

18-Apr-2024 4:05 PM EDT
Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants
Ann and Robert H. Lurie Children's Hospital of Chicago

A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.

Newswise: Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
Released: 23-Apr-2024 3:05 AM EDT
Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
University of the Witwatersrand, Johannesburg

The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.

Released: 16-Apr-2024 7:00 AM EDT
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
University of Texas MD Anderson Cancer Center

MD Anderson and CureVac today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines.

Newswise: Akiko Iwasaki, PhD, receives 2024 Tsukahara Memorial Award
Released: 15-Apr-2024 4:05 PM EDT
Akiko Iwasaki, PhD, receives 2024 Tsukahara Memorial Award
Yale School of Medicine

Yale School of Medicine immunobiologist Akiko Iwasaki, PhD, will receive the 2024 Nakaakira Tsukahara Memorial Award from the Brain Science Foundation of Japan.

Released: 15-Apr-2024 8:30 AM EDT
Dengue: An Emerging Global Crisis - Research and Expert Insights
Newswise Review

Calling All Experts and Researchers: Share Your Insights on Dengue, Prevention, Detection and Vaccines.

Released: 9-Apr-2024 10:05 AM EDT
Republicans who support childhood vaccine mandates often stay silent
Ohio State University

Most Republican voters support childhood vaccine mandates, yet may be discouraged from publicly expressing these views, a new study suggests.

Newswise: Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial
4-Apr-2024 10:00 AM EDT
Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial
Johns Hopkins Medicine

Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma.

Released: 2-Apr-2024 1:05 PM EDT
Received the COVID-19 vaccine but still got the disease? What Your COVID-19 Antibodies May Reveal About Your Recovery
Uniformed Services University of the Health Sciences (USU)

Wondering why some COVID-19 breakthrough cases feel milder than others? A groundbreaking study led by researchers at the Uniformed Services University (USU) sheds light on this phenomenon, offering insights into post-vaccination immunity dynamics.



close
2.5654